Rheumatoid Arthritis
Therapy Uses Adeno-Associated Virus Vector to Deliver Interleukin-1 Receptor Antagonist
Published in Gene Therapy Weekly, April 13th, 2000
They evaluated "recombinant adenoassociated virus vector encoding interleukin-l receptor antagonist (rAAV-IL-1Ra) complementary DNA for its potential in the treatment and prevention of lipopolysaccharide (LPS)-induced arthritis," stated R.Y. Pan and colleagues, National Defense Medical Center, Taiwan.
Pan et al. published the results of their study in the journal Arthritis and Rheumatism ("Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2000-04-13)
More Articles from Gene Therapy Weekly
- Ovarian Cancer
Results from Phase I Trial of Suicide Gene Therapy Encouraging - Sports Medicine
Tissue Engineering to Repair Injuries - Adoptive Immunotherapy
Gene Transfer May Engraft New Specificities onto Lymphocytes - Cancer Gene Therapy
Lymphotactin Gene Transfer Improves Suicide Gene Therapy Efficacy - Cancer Vaccines
Therapy Combines Transduced Interleukin-12 Cells with Systemic Interleukin-18 - Chronic Granulomatous Disease
Gene Therapy Not Yet Effective - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
